Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

6.4K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.4K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

8.8K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
8.8K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.1K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

8.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
SNAREs and Membrane Fusion01:43

SNAREs and Membrane Fusion

10.4K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
10.4K
The Proteasome01:13

The Proteasome

1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitofusin MFN2 acts as a molecular sensor preventing protein aggregation and mitophagy, with a protective effect against apoptosis in Charcot-Marie-Tooth type 2A disease.

Autophagy reports·2026
Same author

Charcot-Marie-Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death.

Journal of cell science·2025
Same author

Ubiquitin precursor with C-terminal extension promotes proteostasis and longevity.

Molecular cell·2025
Same author

Mitofusin 2 displays fusion-independent roles in proteostasis surveillance.

Nature communications·2025
Same author

E4 ubiquitin ligase promotes mitofusin turnover and mitochondrial stress response.

Molecular cell·2023
Same author

Docking and stability defects in mitofusin highlight the proteasome as a potential therapeutic target.

iScience·2023

Related Experiment Video

Updated: May 2, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.4K

Mitofusins: ubiquitylation promotes fusion.

Mafalda Escobar-Henriques1

  • 1Institute for Genetics, Centre for Molecular Medicine (CMMC), Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Zülpicher Str 47a, 50674 Cologne, Germany.

Cell Research
|February 22, 2014
PubMed
Summary

Researchers found 15-oxospiramilactone inhibits USP30, a deubiquitylase impacting mitochondrial proteins Mfn1 and Mfn2. This discovery highlights potential therapeutic targets for diseases linked to mitochondrial gene dysfunction.

More Related Videos

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.6K
In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.3K

Related Experiment Videos

Last Updated: May 2, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.4K
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.6K
In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.3K

Area of Science:

  • Mitochondrial biology
  • Molecular genetics
  • Drug discovery

Background:

  • Mitochondrial genes, such as Mitofusin 2 (Mfn2), are implicated in various diseases.
  • Dysfunctional mitochondria are linked to numerous pathological conditions, making them a key research area.
  • Deubiquitylases (DUBs) play critical roles in protein regulation, including mitochondrial dynamics.

Purpose of the Study:

  • To identify novel chemical inhibitors targeting deubiquitylases involved in mitochondrial function.
  • To explore the therapeutic potential of targeting USP30 for diseases associated with mitochondrial dysfunction.
  • To investigate the effects of small molecules on mitochondrial proteins Mfn1 and Mfn2.

Main Methods:

  • Chemical screening to identify inhibitors of mammalian deubiquitylase USP30.
  • Biochemical assays to confirm the inhibitory activity of 15-oxospiramilactone.
  • Analysis of the effects of the inhibitor on mitochondrial proteins Mfn1 and Mfn2.

Main Results:

  • 15-oxospiramilactone was identified as a chemical inhibitor of the deubiquitylase USP30.
  • The inhibitor was shown to act on mammalian Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2).
  • This finding establishes a link between USP30 inhibition and modulation of key mitochondrial proteins.

Conclusions:

  • 15-oxospiramilactone is a novel inhibitor of USP30, impacting Mfn1 and Mfn2.
  • Targeting USP30 with small molecules like 15-oxospiramilactone presents a potential therapeutic strategy.
  • Further research into USP30 inhibitors could lead to new treatments for mitochondrial-related diseases.